The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by .alpha.-synuclein aggregation. These methods are especially useful in the design and development of inhibitors of Lewy body diseases and other synucleinopathies, and further useful in the treatment of such neurodegenerative diseases, particularly Parkinson's Disease.

 
Web www.patentalert.com

< Protective factors against inflammation, burns and noxious stimuli

> Melanoma antigen peptide analogues

> Modified green fluorescent proteins and methods for using same

~ 00553